Alcon AG | ALC - Selling And Administration Expenses

Stock Price
50.42
Daily Change
0.81 1.63%
Monthly
-21.10%
Yearly
-31.94%
Q2 Forecast
49.42

Alcon AG reported $882M in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
AstraZeneca USD 5.06B 455M Mar/2026
Bayer EUR 3.7B 356M Mar/2026
Essilor EUR 5.62B 4.53B Dec/2025
Fresenius EUR 819M 143M Dec/2025
Fresenius Medical Care EUR 749M 36M Mar/2026
GlaxoSmithKline GBP 2.12B 558M Mar/2026
GRIFOLS EUR 281M 5.7M Mar/2026
Merck EUR 1.6B 136M Dec/2025
Novartis USD 3.14B 296M Mar/2026
Philips EUR 1.18B 121M Mar/2026
Roche Holding CHF 7.28B 3.99B Dec/2025
Sanofi EUR 2.33B 419M Mar/2026
Smith & Nephew USD 1.42B 65M Dec/2025
Sonova Holding CHF 880.2M 300K Jun/2025
UCB EUR 1.47B 193M Dec/2025